Evidence map›Paper›PMID 31382357›Full record

ArticlePharmaceutics2019

Alginate/Chitosan Particle-Based Drug Delivery Systems for Pulmonary Applications.

Marcus Hill, Matthew Twigg, Emer A Sheridan, John G Hardy, J Stuart Elborn, Clifford C Taggart, Christopher J Scott, Marie E Migaud

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Current Status of Alginate in Drug Delivery.Advances in pharmacological and pharmaceutical sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Marcus HillSchool of Pharmacy, Queen's University Belfast Queen's University Belfast, Belfast BT7 1NN, UK.
Matthew TwiggAirway Innate Immunity Group (AiiR), Wellcome Wolfson Institute of Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, Northern Ireland, UK.
Emer A SheridanLancashire Teaching Hospitals NHS Foundation Trust, Royal Preston Hospital, Sharoe Green Lane PR2 9HT, UK.ORCID 0000-0002-1248-5514
John G HardyDepartment of Chemistry, Lancaster University, Lancaster, Lancashire LA1 4YB, UK. j.g.hardy@lancaster.ac.uk.ORCID 0000-0003-0655-2167
J Stuart ElbornSchool of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, Northern Ireland, UK. s.elborn@qub.ac.uk.
Clifford C TaggartAirway Innate Immunity Group (AiiR), Wellcome Wolfson Institute of Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, Northern Ireland, UK. c.taggart@qub.ac.uk.
Christopher J ScottCentre for Cancer Research and Cell Biology, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, Northern Ireland, UK. c.scott@qub.ac.uk.
Marie E MigaudSchool of Pharmacy, Queen's University Belfast Queen's University Belfast, Belfast BT7 1NN, UK. mmigaud@health.southalabama.edu.ORCID 0000-0002-9626-2405
Queen's University Belfast · GBLancashire Teaching Hospitals NHS Foundation Trust · GBLancaster University · GB

Funding

Engineering and Physical Sciences Research Council EP/H031065/1Medical Research Council MC_PC_17192
6 · The paper itself

Abstract

Cystic fibrosis (CF) is a complex, potentially life-threatening disease that is most effectively treated through the administration of antibiotics (e.g., colistimethate sodium). Chronic infection with

Indexed as

antimicrobialbiomedical applicationsdrug delivery systemsparticles

Identifiers

PMID31382357
PMCPMC6722511
OpenAlexW2964550110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.